Please assess the completion status of the following clinical trial:

Trial Title: A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Key Inclusion Criteria:~* Before Surgery:~  * Participant scheduled to undergo a primary unilateral bunionectomy with distal first metatarsal osteotomy (i.e., Austin procedure) and internal fixation under regional anesthesia (Mayo and popliteal sciatic block)~* After Surgery:~  * Participant is lucid and able to follow commands~ * All analgesic guidelines were followed during and after the bunionectomy~Key Exclusion Criteria:~* Before Surgery:~  * Prior history of bunionectomy or other foot surgery on the index foot~ * History of cardiac dysrhythmias requiring anti-arrhythmia treatment(s)~ * Any prior surgery within 1 month before the first study drug~* After Surgery:~  * Participant had a Type 3 deformity requiring a base wedge osteotomy or concomitant surgery such as hammertoe repair, or had medical complications during the bunionectomy that, in the opinion of the investigator, should preclude randomization~Other protocol defined inclusion/exclusion criteria may apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- VX-548 (Type: EXPERIMENTAL): Participants will be randomized to receive different dose levels of VX-548.
- Hydrocodone bitartrate/acetaminophen (HB/APAP) (Type: ACTIVE_COMPARATOR): Participants will receive HB/APAP.
- Placebo (Type: PLACEBO_COMPARATOR): Participants will receive placebos matched to VX-548 and HB/APAP.

Based on this trial design, predict the completion outcome and termination type (if applicable).